
Read More
Mankind Pharma Reports Q4FY26 Results; PAT Jumps 32% YoY, Revenue Crosses R...
Mankind Pharma reported Q4FY26 revenue growth of 11.8 per cent YoY to Rs 3,443 crore, while quarterl...

Mankind Pharma reported Q4FY26 revenue growth of 11.8 per cent YoY to Rs 3,443 crore, while quarterl...

The company’s revenue from operations increased by 31.49 per cent YoY, standing at Rs 996.42 crore i...

The company's revenue from operations in Q2 FY25 stood at Rs 1,325.05 crore, reflecting a 21.1 per c...

This stock is more expensive than MRF. How a Single-Digit Share Value Soared to Six Figures in 4 Mon...

In Q4, FIIs increased their stake, while ace investor Mukul Agrawal has consistently held a 1.06 per...

Shares of the company gained more than 150 per cent in the last six months. ...

Over the past six months the company's shares have generated a stellar return of 75.54 per cent whil...

Shares of the company gained about 45 per cent in the last six months....

Shares have delivered multibagger returns of around 102 per cent over the last year!...

Additionally, the company’s order book stands at Rs 1,108 crore which is 5.50 times of FY23 revenue....